Spotlight: December 2022–January 2023
Updated: Feb 14
Words by Jade Williams
GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering new disease awareness initiatives, landmark drug approvals, mergers and acquisitions and more
08 December 2022
EUCOPE launches Rare Disease Moonshot initiative to find treatments for rare conditions
12 December 2022
Amgen acquires Horizon Therapeutics for $27.8bn
13 December 2022
Novartis joins Roche and Cancer Research UK’s DETERMINE rare cancers study
19 December 2022
CHMP recommends AstraZeneca’s Forxiga in the EU for chronic heart failure
04 January 2023
Moderna makes first acquisition in purchase of OriCiro Genomics for $85m
07 January 2023
FDA approves Eisai and Biogen’s Alzheimer’s disease treatment lecanemab
09 January 2023
Deloitte study finds ROI in pharma R&D declined sharply in 2022
10 January 2023
BioNTech acquires InstaDeep to strengthen AI-powered drug development
12 January 2023
HBA names Christi Shaw, CEO, Kite Pharma, as 2023 Woman of the Year
13 January 2023
Moderna extends its roots in the UK by becoming latest member of the ABPI
17 January 2023
Ipsos survey names pharma second most trusted sector in Great Britain
26 January 2023
NICE recommends Gilead’s CAR T-cell therapy for NHS treatment of lymphoma
This news round up appears in GOLD 26 – read the full issue here.
